Lynn Oaks Compounding Pharmacy
FDA inspection history in California, 2022
- 1
- Warning letter
- 1
- Form 483
Every document, by year
- Warning letter
- Form 483
2022: one warning letter and one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2022One warning letter and one Form 483, at California.
Cited most
Across all Lynn Oaks Compounding Pharmacy observations on file
- FDCA 501(a)(2)(A)Insanitary conditions3
- 21 CFR 211.165(a)Testing and release for distribution2
- 21 CFR 211.160(b)(4)General requirements1
- 21 CFR 211.166(a)Stability testing1
The complete Lynn Oaks Compounding Pharmacy file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
California
One warning letter and one Form 483 · 2022 · 7 observations
Latest: Warning letter, Dec 8, 2022 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2022-12-08 | Warning letter Warning letter | California | — | $99 |
| 2022-04-15 | 483 Form 483 | California | 7 | $99 |
Investigators on these documents
FEI number 3021028639 · most recent document Dec 8, 2022
About Lynn Oaks Compounding Pharmacy
How many FDA Form 483s has Lynn Oaks Compounding Pharmacy received?
FDA Intel has 1 Form 483 on file for Lynn Oaks Compounding Pharmacy; the most recent is dated Apr 15, 2022.
When was Lynn Oaks Compounding Pharmacy last inspected by FDA?
The most recent FDA inspection document on file for Lynn Oaks Compounding Pharmacy is a Form 483 dated Apr 15, 2022, for the site in California.
What did FDA cite at Lynn Oaks Compounding Pharmacy?
The regulations cited most in the observations on file for Lynn Oaks Compounding Pharmacy are FDCA 501(a)(2)(A) (Insanitary conditions), 3 times; 21 CFR 211.165(a) (Testing and release for distribution), 2 times; 21 CFR 211.160(b)(4) (General requirements), 1 time.
Has Lynn Oaks Compounding Pharmacy received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Lynn Oaks Compounding Pharmacy; the most recent is dated Dec 8, 2022.